secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K/A
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0001171843-23-000010
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience sets compensation for Interim CFO Cote: $270K salary, bonus, $75K RSU
--------------------------------------------------------------------------------

- Annual base salary of $270,000 as Interim CFO and Treasurer, effective January 1, 2023.
- Eligible for cash bonus of 25% of 2023 base salary, paid in quarterly installments.
- One-time equity award of RSUs with $75,000 grant date value, vesting December 29, 2023.
- Compensation package is in addition to prior VP Finance terms from April 2022 offer letter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323000010/0001171843-23-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323000010/f8ka_010323.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer